Form D · Pharmaceuticals

Castle Creek Pharmaceuticals, LLC

Bedminster, NJ · CIK 0001687481

Offering snapshot reported Oct 17, 2016 · SEC filing

Reported sold: $48M
Investors reported: 6
Minimum accepted: $0
First sale: Sep 29, 2016

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 17, 2016	Amendment	$48,000,150	$0vs Oct 14, 2016	6	SEC filing
Oct 14, 2016	Initial	$48,000,150	No comparison	6	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $1.92M
Finders' fees: $0
Form D file number: 021-272558

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Octagon Capital Group, LLC	173341

Source: Form D, filed Oct 17, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Jeffrey Aronin	Director
Timothy Cunniff	Director
Michael Derby	Director, Executive
Antonio Gracias	Director
Greg Licholai	Executive
Patrick Morris	Director
N/A Octagon Capital Group, Llc	Promoter

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

90 Washington Valley Road
Bedminster, NJ, 07921